BACE1 inhibitors for the treatment of Alzheimer's disease
Abstract:
Described herein are compounds of the formulae (I)-(III) as well as pharmaceutical compositions comprising such compounds and methods for using such compounds/pharmaceutical compositions for treating Alzheimer's disease.
Public/Granted literature
Information query
Patent Agency Ranking
0/0